RVMD Revolution Medicines posted 52% response rates in lung cancer trials over the weekend at AACR 2026. The biotech grabbed premarket attention as bulls positioned ahead of momentum. XENE Xenon Pharma surged on Phase 3 epilepsy data showing 53% seizure reduction triggering options flow through July.
BLD TopBuild jumped 20% premarket on undisclosed catalysts. The construction products name commanded the most dramatic single-stock move ahead of the open. HLIT Harmonic gained on news its VOS Media Software powers DIRECTV's platform modernization.
ASTS AST SpaceMobile faces orbital failure after BlueBird 7 landed below operational altitude. The New Glenn upper stage malfunction forces satellite de-orbit though insurance covers costs. The space broadband name absorbed $271M in insider selling earlier this month as Mickey Mikitani liquidated his 10% stake.
Entertainment microcaps dominated short seller activity. LRHC La Rosa Holdings SI exploded 282 points to 334% of float with cost to borrow hitting 292%. SNAL Snail grabbed bears jumping 75 points to 75% SI from near zero in seven days.
Financial Times reported private credit faces scrutiny as JPMorgan and Barclays now trade derivatives betting on pain in Apollo, Ares and Blackstone funds. The EU plans its biggest merger rule relaxation in decades as Europe embraces mega M&A.
Oil markets showed bifurcation as biodiesel dropped below regular diesel for the first time. The Iran war continues squeezing supplies driving scrambles for replacement barrels. Asian markets fell on Middle East ceasefire fragility while European stocks closed near flat.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
